Table 3

 Summary of results by study design

Study designNumber (%) of studies (n = 90)Number (% of this design) reporting higher CRP in cases than the comparison group
CRP, C reactive protein.
*The number of studies cited here does not add up to the total number of prevalent studies, as some studies included several comparison groups.
Prevalent case–control/cross sectional81 (90.0)55 (67.9)
Included healthy comparison group55 (61.1)*49 (89.1)
Included comparison group with any benign disease43 (47.8)19 (44.2)
Prospective9 (10.0)5 (55.6)
Included healthy comparison group9 (10.0)5 (55.6)
Included comparison group with any benign disease0 (0)0 (0)